The Netherlands
Ansana, founded in 2022, is making significant strides with its cutting-edge sterilization technology primarily aimed at the healthcare and pharmaceutical sectors. Positioned as "The standard in sterilization process management and control," the company is pioneering an intelligent sterilization container that ensures both sterility and traceability, benefiting hospital and industrial workflows.
The company's solution not only reduces patient risks but also decreases environmental impact while effectively lowering costs and streamlining operations. Headquartered in The Netherlands, Ansana operates at the intersection of Healthcare, Manufacturing, Medical Devices, and Pharmaceutical industries, offering a compelling market appeal.
In its most recent financing round, Ansana secured a €1.50M seed investment in September 2025, backed by prominent investors such as Health Venture and bgo ventures, indicating strong confidence in its innovative approach and market potential.
